Achieve Life Sciences, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ACHV on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
22722 29 Th Dr. Se, Suite 100, Seattle, WA

Insiders trading volume in the past year

Achieve Life Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dialectic Capital Management, Lp 10%+ Owner $19.5M Nov 18, 2022
K. Oki Chief Financial Officer $617K Dec 6, 2024
John Bencich CEO, Director $369K +$45.9K +14.2% Aug 16, 2024
Richard Stewart Executive Chairman, Director $229K +$45.9K +25% Apr 19, 2024
Cindy Jacobs President & CMO, Director $122K Aug 16, 2024
Jaime Xinos Chief Commercial Officer $96.5K Dec 6, 2024
Jerry Wan Principal Accounting Officer $46.5K Aug 16, 2024
Anthony Clarke Cso $39.5K Apr 28, 2022
Donald Joseph Director May 31, 2022
Thomas Sellig Director Jan 22, 2024
Martin A. Mattingly Director May 31, 2022
Thomas B. King Director Jan 22, 2024
Svb Financial Group 10%+ Owner Nov 18, 2022
Vaughn Himes Director Jan 22, 2024
Stuart Duty Director Jan 22, 2024
Jay M. Moyes Director May 31, 2022
Bridget Martell Director Jan 22, 2024

Recent Insider Transactions by Companies or Individuals for Achieve Life Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.